Literature DB >> 15809929

A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Jian-Jun Chen1, Wei Huang, Jin-Ping Gui, Sen Yang, Fu-Sheng Zhou, Quan-Geng Xiong, Hong-Bo Wu, Yong Cui, Min Gao, Wei Li, Jin-Xian Li, Kai-Lin Yan, Wen-Tao Yuan, Shi-Jie Xu, Jian-Jun Liu, Xue-Jun Zhang.   

Abstract

Generalized vitiligo is a common, autoimmune, familial-clustering depigmentary disorder of the skin and hair that results from selective destruction of melanocytes. Generalized vitiligo is likely a heterogeneous disease, with five susceptibility loci reported so far--on chromosomes 1p31, 6p21, 7q, 8p, and 17p13--in white populations. To investigate vitiligo susceptibility loci in the Chinese population, we performed a genomewide linkage analysis in 57 multiplex Chinese families, each with at least two affected siblings, and we identified interesting linkage evidence on 1p36, 4q13-q21, 6p21-p22, 6q24-q25, 14q12-q13, and 22q12. Subsequently, to extract more linkage information, we investigated our initial genomewide linkage findings in a follow-up analysis of 49 new families and additional markers. Our initial genomewide linkage analysis and our subsequent follow-up analysis have identified a novel linkage to vitiligo on 4q13-q21, with highly significant linkage evidence (a nonparametic LOD score of 4.62 [P=.000003] and a heterogeneity LOD score of 4.01, under a recessive inheritance model), suggesting that 4q13-q21 likely harbors a major susceptibility locus for vitiligo in the Chinese population. We observed a minimal overlap between the linkage results of our current genomewide analysis in the Chinese population and the results of previous analyses in white populations, and we thus hypothesize that, as a polygenic disorder, vitiligo may be associated with great genetic heterogeneity and a substantial difference in its genetic basis between ethnic populations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809929      PMCID: PMC1196443          DOI: 10.1086/430279

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  All LODs are not created equal.

Authors:  D R Nyholt
Journal:  Am J Hum Genet       Date:  2000-07-06       Impact factor: 11.025

2.  Linkage and association of HLA class II genes with vitiligo in a Dutch population.

Authors:  M Zamani; M Spaepen; S S Sghar; C Huang; W Westerhof; L Nieuweboer-Krobotova; J J Cassiman
Journal:  Br J Dermatol       Date:  2001-07       Impact factor: 9.302

3.  Merlin--rapid analysis of dense genetic maps using sparse gene flow trees.

Authors:  Gonçalo R Abecasis; Stacey S Cherny; William O Cookson; Lon R Cardon
Journal:  Nat Genet       Date:  2001-12-03       Impact factor: 38.330

Review 4.  Evidence for an autoimmune pathogenesis of vitiligo.

Authors:  Katia Ongenae; Nanny Van Geel; Jean-Marie Naeyaert
Journal:  Pigment Cell Res       Date:  2003-04

5.  Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus.

Authors:  S K Nath; J A Kelly; B Namjou; T Lam; G R Bruner; R H Scofield; C E Aston; J B Harley
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

6.  A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci.

Authors:  Pamela R Fain; Katherine Gowan; Greggory S LaBerge; Asem Alkhateeb; Gary L Stetler; Janet Talbert; Dorothy C Bennett; Richard A Spritz
Journal:  Am J Hum Genet       Date:  2003-04-18       Impact factor: 11.025

7.  Characteristics of vitiligo in Korean children.

Authors:  S Cho; H C Kang; J H Hahm
Journal:  Pediatr Dermatol       Date:  2000 May-Jun       Impact factor: 1.588

8.  Genetic association of the catalase gene (CAT) with vitiligo susceptibility.

Authors:  Courtney B Casp; Jin-Xiong She; Wayne T McCormack
Journal:  Pigment Cell Res       Date:  2002-02

9.  CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases.

Authors:  Anne Blomhoff; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Eystein S Husebye; Hanne E Akselsen; Benedicte A Lie; Dag E Undlien
Journal:  Pigment Cell Res       Date:  2005-02

10.  Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo.

Authors:  Anna Wańkowicz-Kalińska; René M J G J van den Wijngaard; Bert J Tigges; Wiete Westerhof; Graham S Ogg; Vincenzo Cerundolo; Walter J Storkus; Pranab K Das
Journal:  Lab Invest       Date:  2003-05       Impact factor: 5.662

View more
  23 in total

Review 1.  Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease.

Authors:  Richard A Spritz
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 2.  Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.

Authors:  Katia Boniface; Julien Seneschal; Mauro Picardo; Alain Taïeb
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Genetics of Vitiligo.

Authors:  Richard A Spritz; Genevieve H L Andersen
Journal:  Dermatol Clin       Date:  2017-04       Impact factor: 3.478

4.  Update on the genetics characterization of vitiligo.

Authors:  Hani A Al-Shobaili
Journal:  Int J Health Sci (Qassim)       Date:  2011-07

5.  Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC.

Authors:  Cheng Quan; Yun-Qing Ren; Lei-Hong Xiang; Liang-Dan Sun; Ai-E Xu; Xing-Hua Gao; Hong-Duo Chen; Xiong-Ming Pu; Ri-Na Wu; Chao-Zhao Liang; Jia-Bin Li; Tian-Wen Gao; Jian-Zhong Zhang; Xiu-Li Wang; Jun Wang; Rong-Ya Yang; Ling Liang; Jian-Bin Yu; Xian-Bo Zuo; Sheng-Quan Zhang; Shu-Mei Zhang; Gang Chen; Xiao-Dong Zheng; Pan Li; Jun Zhu; Yong-Wei Li; Xiao-Dong Wei; Wei-Song Hong; Ying Ye; Yong Zhang; Wei-Su Wu; Hui Cheng; Pu-Ling Dong; Da-Yan Hu; Yang Li; Min Li; Xin Zhang; Hua-Yang Tang; Xian-Fa Tang; Sheng-Xin Xu; Su-Min He; Yong-Mei Lv; Min Shen; Hong-Quan Jiang; Ying Wang; Kai Li; Xiao-Jing Kang; Yu-Qin Liu; Li Sun; Zhi-Fang Liu; Shao-Qiong Xie; Cheng-Yao Zhu; Qiang Xu; Jin-Ping Gao; Wen-Long Hu; Cheng Ni; Ting-Meng Pan; Yun Li; Sha Yao; Cai-Feng He; Yang-Sheng Liu; Ze-Ying Yu; Xian-Yong Yin; Feng-Yu Zhang; Sen Yang; Youwen Zhou; Xue-Jun Zhang
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

6.  Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis.

Authors:  Cheryl L Thompson; Benjamin A Rybicki; Michael C Iannuzzi; Robert C Elston; Sudha K Iyengar; Courtney Gray-McGuire
Journal:  Am J Hum Genet       Date:  2006-08-10       Impact factor: 11.025

7.  Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

Authors:  Stanca A Birlea; Ying Jin; Dorothy C Bennett; Deborah M Herbstman; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanja van Geel; Jo Lambert; Andreas Overbeck; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2010-11-18       Impact factor: 8.551

8.  Meta-analysis of genome-wide linkage studies across autoimmune diseases.

Authors:  Paola Forabosco; Emmanuelle Bouzigon; Mandy Y Ng; Jane Hermanowski; Sheila A Fisher; Lindsey A Criswell; Cathryn M Lewis
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

Review 9.  Modern vitiligo genetics sheds new light on an ancient disease.

Authors:  Richard A Spritz
Journal:  J Dermatol       Date:  2013-05       Impact factor: 4.005

10.  Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.

Authors:  Yunqing Ren; Sen Yang; Shengxin Xu; Min Gao; Wei Huang; Tianwen Gao; Qiaoyun Fang; Cheng Quan; Chi Zhang; Liangdan Sun; Yanhua Liang; Jianwen Han; Zhimin Wang; Fengyu Zhang; Youwen Zhou; Jianjun Liu; Xuejun Zhang
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.